For NEPHROCARE, treating renal patients means reducing morbidity and mortality in all aspects of chronic renal failure including uraemic disorders and dialysis-related complications.

The term describes the unique potential of the products of Fresenius Medical Care to deliver optimal dialysis therapies in the most biocompatible way. Dialysis therapies provided with this state-of-the-art technology prolong patient survival and minimize the complications and comorbidity associated with end-stage renal disease. NEPHROCARE and its partners enjoy the option of unlimited access to the superior products of Fresenius Medical Care thus enabling patients and their care providers to benefit from a comprehensive range of treatments designed to provide optimal outcomes.